CALYXT INC (CLXT)
US13173L2060 - Common Stock
CALYXT INC
NASDAQ:CLXT (5/31/2023, 7:09:09 PM)
After market: 6.99 +0.69 (+10.95%)6.3
+0.33 (+5.53%)
Company Profile
Calyxt Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Roseville, Minnesota and currently employs 25 full-time employees. The company went IPO on 2017-07-20. Calyxt, Inc. is a plant-based synthetic biology company. The firm is focused on research and development, including gene editing, plant breeding, and trait development. The company specializes in engineering plant metabolisms. The firm leverages its PlantSpring technology platform to engineer plant metabolism to produce sustainable materials and products for use in helping customers meet. The firm operates through the development and commercialization of products derived from plant cells. Its platform provides plant-based synthetic biology solutions to customers across multiple industries. The firm has engineered plant metabolism into products including soybeans with improved fatty-acid profiles and alfalfa able to be better digested by livestock. Its product pipeline includes hemp, winter oats, and high saturated fat soybeans. Hemp serves a range of varieties of materials science needs, including strengthening plastics and reducing petroleum-based content.
Company Info
CALYXT INC
2800 Mount Ridge Rd
Roseville MINNESOTA 55113
P: 16516832807.0
CEO: Yves Ribeill
Employees: 25
Website: https://calyxt.com/
CLXT News
a year ago - Seeking AlphaCalyxt stockholders approve merger and reverse stock split (NASDAQ:CLXT)Calyxt (CLXT) held a special meeting of its stockholders on May 18, where stockholders voted in favor of all proposals, including the issuance of shares of Class A and Class B common...
a year ago - Calyxt, Inc.Calyxt Announces Stockholder Approval of Merger With Cibus/PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT) ("Calyxt" or the "Company") today announced the results of the special meeting of its stockholders held on May 18,...
a year ago - Calyxt, Inc.Calyxt Reports First Quarter 2023 Financial Results and Provides Corporate Update/PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced operating and financial results for its first quarter...
a year ago - Calyxt, Inc.Calyxt Completes One-for-Ten Reverse Stock Split/PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT) ("Calyxt" or the "Company") today announced that it has completed the previously announced reverse stock split of...
a year ago - Calyxt, Inc.Calyxt Announces Effective Date of Reverse Stock Split/PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT) ("Calyxt" or the "Company") today announced that it will proceed with the 1-for-10 reverse stock split previously...
a year ago - Cellectis Inc.Calyxt, Inc. Reports its Fourth Quarter 2022 Financial Results and Provides Corporate UpdateCLXT Twits
Here you can normally see the latest stock twits on CLXT, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
